1. Home
  2. Live Updates
  3. டோயாமா இரசாயன இணை லிமிடெட்

Page 2 - டோயாமா இரசாயன இணை லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டோயாமா இரசாயன இணை லிமிடெட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டோயாமா இரசாயன இணை லிமிடெட் Today - Breaking & Trending Today

Dr. Reddy's and GRA announces Avigan Pivotal Studies Update

Dr. Reddy s and GRA announces Avigan Pivotal Studies Update ....

United States , Appili Therapuetics , Reddy Laboratories Ltd , Toyama Chemical Co Ltd , Avigan Pivotal Studies , Time Zone , Global Response Aid , Avigan Trial Study , North America , Mutual Funds , New Issue , Public Issue , Rights Issue , Stock Markets , Post Office , National Savings Scheme , Kisan Vikas Patra , Public Provident Fund , Goi Senior Citizens Savings Scheme , 8 Bonds , Tax Plan , Investor Forum , ஒன்றுபட்டது மாநிலங்களில் , சிவப்பு ஆய்வகங்கள் லிமிடெட் , டோயாமா இரசாயன இணை லிமிடெட் , நேரம் ஸோந் ,

Coronavirus: Dr. Reddy's Lab terminates trial study of Avigan in Kuwait


Coronavirus: Dr. Reddy’s Lab terminates trial study of Avigan in Kuwait
Ashish Pandey
Hyderabad based Dr. Reddy s Laboratories on Wednesday announced the termination of Avigan Trial Study conducted in Kuwait focused on moderate to severe COVID-19 patients.
The hospitalized patient study, conducted in Kuwait, on moderate to severe patients was one of the studies in the overall clinical program for Avigan, spanning the spectrum of Asymptomatic to severe cases of Covid in both outpatient and in-patient setting.
However, the company said that it will continue ten Phase-III studies in an outpatient setting on patients with mild to moderate symptoms in North America with its partner with Appili Therapeutics and Global Response Aid. ....

United States , Andhra Pradesh , Toyama Chemical Co Ltd , Avigan Trial Study , North America , Appili Therapeutics , Global Response , ஒன்றுபட்டது மாநிலங்களில் , ஆந்திரா பிரதேஷ் , டோயாமா இரசாயன இணை லிமிடெட் , வடக்கு அமெரிக்கா , உலகளாவிய பதில் ,

Dr. Reddy's Laboratories, Global Response Aid, and Appili Therapeutics Announce the Filing of an Application for REEQONUS (favipiravir) Tablets for the Treatment of COVID-19 under Health Canadas Interim Order


Posted on
10423
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), Appili Therapeutics (TSX: APLI, OTCQX: APLIF) and Global Response Aid FZCO (GRA) today announced that Dr. Reddy’s Canada has filed an application on behalf of the consortium for REEQONUS™ (favipiravir) Tablets for the acute treatment of mild to moderate COVID-19 adult patients under Health Canada’s Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. REEQONUS™ is also known as Avigan® (favipiravir) Tablets, developed by FUJIFILM Toyama Chemical Co., Ltd. ....

United Arab Emirates , United States , Mitch Wilson , Vinod Ramachandran , Armand Balboni , Services Active Ingredients , Reddy Laboratories Canada Inc , Exchange Commission , Health Canada Interim Order , Holdings Corporation , Health Canada Interim Order Respecting The Importation , Reddy Laboratories Ltd , Health Canada , Toyama Chemical Co Ltd , Appili Therapeutics , Global Response Aid , Interim Order Respecting , Interim Order , Vice President , General Manager , Laboratories Canada , Chief Executive Officer , Pharmaceutical Services , Active Ingredient , Global Generics , Proprietary Products ,